Bristol-Myers Squibb Company Ce
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CELG-RI research report →
Companywww.bms.com
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
- CEO
- Christopher S. Boerner
- IPO
- 2019
- Employees
- 34,100
- HQ
- Princeton, NJ, US
Price Chart
Valuation
- Market Cap
- $224.63M
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.00
Profitability
- Gross Margin
- 96.16%
- Op Margin
- 33.97%
- Net Margin
- 26.48%
- ROE
- 61.86%
- ROIC
- 13.62%
Growth & Income
- Revenue
- $48.19B · -0.22%
- Net Income
- $7.05B · 178.83%
- EPS
- $3.47 · 178.68%
- Op Income
- $15.12B
- FCF YoY
- -7.87%
Performance & Tape
- 52W High
- $0.16
- 52W Low
- $0.11
- 50D MA
- $0.10
- 200D MA
- $0.07
- Beta
- -0.71
- Avg Volume
- 38.68K
Get TickerSpark's AI analysis on CELG-RI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 1, 24 | Poole Ahn Amanda | other | 0 |
| Jan 1, 24 | Poole Ahn Amanda | other | 4,822 |
| Jan 1, 24 | Poole Ahn Amanda | other | 3,214 |
| Dec 31, 23 | YALE PHYLLIS R | other | 657.767 |
| Dec 31, 23 | Storch Gerald L | other | 706.49 |
| Dec 31, 23 | Samuels Theodore R. II | other | 950.107 |
| Dec 31, 23 | Rice Derica W | other | 706.49 |
| Dec 31, 23 | Hidalgo Medina Manuel | other | 164.442 |
| Dec 31, 23 | Haller Julia A | other | 706.49 |
| Dec 31, 23 | Bhatt Deepak | other | 164.442 |
Our CELG-RI Coverage
We haven't published any research on CELG-RI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CELG-RI Report →